Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
IL-2 cultures fail to measure chromosomal radiosensitivity in study patients
February 10th, 2005
Researchers from Belgium reported that IL-2 cultures failed to measure chromosomal radiosensitivity in breast cancer patients that was observed in whole blood cultures from the same blood samples. A. Vral and colleagues wrote in Mutagenesis, "Enhanced chromosomal radiosensitivity in breast cancer patients has been demonstrated in several studies. To investigate the chromosomal radiosensitivity of lymphocytes in breast cancer patients the G(2) and micronucleus (MN) assays are often used. "In these assays blood samples are exposed to ionizing radiation and the number of radiation-induced micronuclei or chromatid breaks are scored." ...
Source: Women's Health Weekly (2005-02-10)
|
